A rumored takeover candidate is among the five small-cap biotech stocks trading under $10 highlighted in today’s article, all of which boast Buy ratings from well-known Wall Street firms – and solid upside potential. For these five biotech stocks, which are suited for very aggressive investors, CLICK HERE.
5 Small-Cap Biotech Stocks Under $10 With Buy Ratings – And Solid Alpha Potential
Tags:Aggressive InvestorsBiotech StocksBuy RatingsInvestinvestorSmall-Cap Biotech StocksSolid Alpha PotentialStock MarketStocks Under $10Trades Under $10Upside PotentialWall Street Firms